|
WO2014167579A2
|
|
Stable pharmaceutical compositions of tadalafil
|
|
WO2014167575A2
|
|
Stable tigecycline composition
|
|
WO2014141298A2
|
|
Stable pharmaceutical composition of fingolimod
|
|
WO2013160909A1
|
|
Stable composition of fesoterodine
|
|
WO2013102920A1
|
|
Stable lyophilized formulation of bendamustine
|
|
WO2013093934A1
|
|
Process for preparation of decitabine injection
|
|
EP2648755A1
|
|
A stable ready-to-use cetrorelix injection
|
|
EP2459170A2
|
|
A stable composition of ready-to-use gemcitabine injection
|
|
WO2009118754A2
|
|
A process for preparing a stable lyophilized composition
|
|
WO2007122635A2
|
|
Controlled release formulation comprising anti-epileptic drugs
|
|
WO2007086079A2
|
|
Sustained release dosage form of phenothiazine derivatives containing channelizer
|
|
US2007166375A1
|
|
Modified release oral dosage form using co-polymer of polyvinyl acetate
|
